As a leading healthcare company, our goal is to continue to develop innovative medicines and diagnostics that address unmet medical needs and are of real value to society. We aim to provide real improvements in patients health and their quality and length of life - this is our core contribution. We are committed to achieving our aim in a responsible and sustainable manner and we do this by:
Respecting the needs of the individual, society and the environment.
Meeting high standards of performance in business practices and ethics by ensuring our values of integrity, courage and passion guide the daily behaviour and decisions of all employees.
Working with governments and healthcare providers to help develop effective policies relating to public health and access to medicines and diagnostics.
Encouraging employee participation in, and providing corporate sponsorship for a wide range of health, education and social service programs and activities.
Contributing to the Millennium Development Goals.
Philanthropic Donations and non-commercial Sponsorship.
We are involved in the following CSI initiatives:
The Public Healthcare Enhancement Fund
As a result of interactions between a number of healthcare companies and associations and the Minister, the Deputy Minister and the Director General of Health, the SA Joint Public Enhancement Fund (SAJPHEF), a not for profit company was established in 2013.
SAJPHEF will be the financing instrument through which member companies to the Social Compact will make fixed annual contributions into the fund. Roche, together with partner companies, associations and the DoH will jointly select initiatives in the areas of human resource development and expansion, management capacity building HIV/AIDS and TB.
The main aim of the partnership is to strengthen the relationship between private and public sectors and to build a partnership between the two.
Partnership through this Social Compact aims to:
1. Leverage the common purpose of the private sector through the pooling of CSI resources, providing a less fragmented approach to socio-economic development in the sector.
2. The identification and joint execution of initiatives in the areas of human resourcing, capacity building and HIV/AIDS and TB, that will contribute to the strengthening of the public system.
3. Enhance collaboration between the public and private healthcare sectors through ongoing sustainable and structured engagement between the two.
The Charlotte Maxeke Oncology Unit project
Roche has embarked on a number of community projects, such as the upgrading and modernisation of the Charlotte Maxeke Oncology Unit.
The development of the facility not only provided cancer patients receiving treatment with more comfortable surroundings, but also ensured that the medical teams continue to provide quality care to in- and outpatients receiving treatment at the unit. The isolation wards were also increased from 4 to 7, almost doubling the number of patients who could be assisted at one time.